Clinical trial
Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in…
NCT00137748 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00137748 |
|---|---|
| Title | Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients |
| Official title | Does Replacement With CMVIG in Hypogammaglobulinemic Patients Decrease the Rate of Opportunistic Infections and Chronic Rejection? |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hypogammaglobulinemia |
| Intervention type | Drug |
| Interventions | CMV-Ig |
| Enrollment | 50 |
| Start date | Jan 1, 2001 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Aug 30, 2005 |
| Last update posted | Jun 10, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: